Literature DB >> 20688587

CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease.

Maria Assunta Zocco1, Anna Chiara Piscaglia, Felice Giuliante, Vincenzo Arena, Marialuisa Novi, Emanuele Rinninella, Annalisa Tortora, Carlo Rumi, Gennaro Nuzzo, Fabio Maria Vecchio, Giuseppe Bombardieri, Antonio Gasbarrini.   

Abstract

BACKGROUND: Bone marrow stem cells (BMSC) can participate to liver regeneration. However, conflicting results have been reported on this topic in patients undergoing liver resection. AIMS: To assess the impact of liver resection extent and presence of underlying liver disease in modulating BMSC mobilization.
METHODS: We enrolled 29 patients undergoing liver resection of different extents, 5 surgical controls and 10 blood donors. Circulating CD133+ BMSC were measured by flow cytometry at different time-points after surgery. The hepatic commitment of mobilized BMSC was investigated by polymerase chain reaction. Liver specimens were collected during surgery for histopathological analysis. Hepatocyte growth factor and granulocyte-colony stimulating factor serum levels were measured by enzyme-linked immunosorbent assay.
RESULTS: BMSC mobilization was found in patients undergoing major liver resection, especially in the presence of underlying disease. Ductular reactions were noted in patients with chronic hepatopathy and the hepatic progenitor-like cells expressed CD133, NCAM, cytokeratin-19, and alpha-fetoprotein. Hepatocyte growth factor and granulocyte-colony stimulating factor levels increased following liver resection and the contemporaneous presence of liver disease was associated with their highest raise.
CONCLUSIONS: Liver repair is mainly an endogenous process. BMSC become important in case of extensive resection, especially in the presence of underlying hepatopathy and hepatic progenitor-like cells activation. Hepatocyte growth factor and granulocyte-colony stimulating factor seem to be involved in the dynamics underlying hepatic regeneration and BMSC recruitment.
Copyright © 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688587     DOI: 10.1016/j.dld.2010.06.008

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  6 in total

Review 1.  Effect of liver regeneration on malignant hepatic tumors.

Authors:  Ji-Hua Shi; Pål-Dag Line
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

2.  CD34+ hematopoietic stem cells mobilization, paralleled with multiple cytokines elevated in patients with HBV-related acute-on-chronic liver failure.

Authors:  Zhihong Wan; Shaoli You; Yihui Rong; Bing Zhu; Aimin Zhang; Hong Zang; Long Xiao; Guoming Xie; Shaojie Xin
Journal:  Dig Dis Sci       Date:  2012-10-25       Impact factor: 3.199

3.  Cross effects of resveratrol and mesenchymal stem cells on liver regeneration and homing in partially hepatectomized rats.

Authors:  Erdem Okay; Turgay Simsek; Cansu Subasi; Abdullah Gunes; Gokhan Duruksu; Yesim Gurbuz; Gulcin Gacar; Erdal Karaoz
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

4.  Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluation.

Authors:  Silvia Gaia; Antonella Olivero; Antonina Smedile; Marco Ruella; Maria Lorena Abate; Maurizio Fadda; Emanuela Rolle; Paola Omedè; Paola Bondesan; Roberto Passera; Alessandra Risso; Manuela Aragno; Alfredo Marzano; Alessia Ciancio; Mario Rizzetto; Corrado Tarella
Journal:  Hepatol Int       Date:  2013-10-11       Impact factor: 6.047

5.  Signals and cells involved in regulating liver regeneration.

Authors:  Liang-I Kang; Wendy M Mars; George K Michalopoulos
Journal:  Cells       Date:  2012-12-13       Impact factor: 6.600

6.  Biological effects of bone marrow mesenchymal stem cells on hepatitis B virus in vitro.

Authors:  Wei-Ping Zheng; Bo-Ya Zhang; Zhong-Yang Shen; Ming-Li Yin; Yi Cao; Hong-Li Song
Journal:  Mol Med Rep       Date:  2017-03-15       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.